167 related articles for article (PubMed ID: 35998012)
1. Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents.
Torrens L; Puigvehí M; Torres-Martín M; Wang H; Maeda M; Haber PK; Leonel T; García-López M; Esteban-Fabró R; Leow WQ; Montironi C; Torrecilla S; Varadarajan AR; Taik P; Campreciós G; Enkhbold C; Taivanbaatar E; Yerbolat A; Villanueva A; Pérez-Del-Pulgar S; Thung S; Chinburen J; Letouzé E; Zucman-Rossi J; Uzilov A; Neely J; Forns X; Roayaie S; Sia D; Llovet JM
Clin Cancer Res; 2022 Oct; 28(20):4509-4520. PubMed ID: 35998012
[TBL] [Abstract][Full Text] [Related]
2. The genomic landscape of Mongolian hepatocellular carcinoma.
Candia J; Bayarsaikhan E; Tandon M; Budhu A; Forgues M; Tovuu LO; Tudev U; Lack J; Chao A; Chinburen J; Wang XW
Nat Commun; 2020 Sep; 11(1):4383. PubMed ID: 32873799
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.
Pinyol R; Torrecilla S; Wang H; Montironi C; Piqué-Gili M; Torres-Martin M; Wei-Qiang L; Willoughby CE; Ramadori P; Andreu-Oller C; Taik P; Lee YA; Moeini A; Peix J; Faure-Dupuy S; Riedl T; Schuehle S; Oliveira CP; Alves VA; Boffetta P; Lachenmayer A; Roessler S; Minguez B; Schirmacher P; Dufour JF; Thung SN; Reeves HL; Carrilho FJ; Chang C; Uzilov AV; Heikenwalder M; Sanyal A; Friedman SL; Sia D; Llovet JM
J Hepatol; 2021 Oct; 75(4):865-878. PubMed ID: 33992698
[TBL] [Abstract][Full Text] [Related]
4. Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.
Zhang W; He H; Zang M; Wu Q; Zhao H; Lu LL; Ma P; Zheng H; Wang N; Zhang Y; He S; Chen X; Wu Z; Wang X; Cai J; Liu Z; Sun Z; Zeng YX; Qu C; Jiao Y
Gastroenterology; 2017 Jul; 153(1):249-262.e2. PubMed ID: 28363643
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
6. Aflatoxin exposure may not play a role in liver cancer development in Mongolia.
Popp W; Gantumur T; Ross B; Zorigt K; Davaadorj D; Rossburg M; Sowa JP; Canbay A
Digestion; 2014; 89(4):268-71. PubMed ID: 25011557
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma and its early detection by AFP testing in Mongolia.
Oyunsuren T; Sanduijav R; Davaadorj D; Nansalmaa D
Asian Pac J Cancer Prev; 2006; 7(3):460-2. PubMed ID: 17059345
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of genomic and immunological profiles in Chinese and Western hepatocellular carcinoma populations.
Li W; Wu H; Xu X; Zhang Y
Aging (Albany NY); 2021 Apr; 13(8):11564-11594. PubMed ID: 33867349
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of APOB inactivation in hepatocellular carcinoma.
Lee G; Jeong YS; Kim DW; Kwak MJ; Koh J; Joo EW; Lee JS; Kah S; Sim YE; Yim SY
Exp Mol Med; 2018 Nov; 50(11):1-12. PubMed ID: 30429453
[TBL] [Abstract][Full Text] [Related]
10. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
11. Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
Diaz G; Engle RE; Tice A; Melis M; Montenegro S; Rodriguez-Canales J; Hanson J; Emmert-Buck MR; Bock KW; Moore IN; Zamboni F; Govindarajan S; Kleiner DE; Farci P
Mol Cancer Res; 2018 Sep; 16(9):1406-1419. PubMed ID: 29858376
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Chronic Hepatitis B and C Infection in Mongolian Immigrants in the Washington, District of Columbia, Metropolitan Area, 2016-2017.
Ha E; Kim F; Blanchard J; Juon HS
Prev Chronic Dis; 2019 Jan; 16():E08. PubMed ID: 30676936
[TBL] [Abstract][Full Text] [Related]
13. Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia.
Kurbanov F; Tanaka Y; Elkady A; Oyunsuren T; Mizokami M
J Viral Hepat; 2007 Sep; 14(9):667-74. PubMed ID: 17697020
[TBL] [Abstract][Full Text] [Related]
14.
Ho DWH; Chan LK; Chiu YT; Xu IMJ; Poon RTP; Cheung TT; Tang CN; Tang VWL; Lo ILO; Lam PWY; Yau DTW; Li MX; Wong CM; Ng IOL
Gut; 2017 Aug; 66(8):1496-1506. PubMed ID: 27974549
[TBL] [Abstract][Full Text] [Related]
15. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
16. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
[TBL] [Abstract][Full Text] [Related]
17. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses.
Oyunsuren T; Kurbanov F; Tanaka Y; Elkady A; Sanduijav R; Khajidsuren O; Dagvadorj B; Mizokami M
J Med Virol; 2006 Dec; 78(12):1688-95. PubMed ID: 17063518
[TBL] [Abstract][Full Text] [Related]
18. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
19. Integrated genomic analyses of hepatocellular carcinoma.
Chang YS; Tu SJ; Chen HD; Hsu MH; Chen YC; Chao DS; Chung CC; Chou YP; Chang CM; Lee YT; Yen JC; Jeng LB; Chang JG
Hepatol Int; 2023 Feb; 17(1):97-111. PubMed ID: 36472800
[TBL] [Abstract][Full Text] [Related]
20. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
